Deubiquitinating Enzyme: A Potential Secondary Checkpoint of Cancer Immunity

The efficacy of cancer immunotherapy depends on the fine interplay between tumoral immune checkpoints and host immune system. However, the up-to-date clinical performance of checkpoint blockers in cancer therapy revealed that higher-level regulation should be further investigated for better therapeu...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Xing, Zhang, Xiaozhen, Xu, Jian, Wang, Xun, Zhang, Gang, Tang, Tianyu, Shen, Xiaochao, Liang, Tingbo, Bai, Xueli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7426525/
https://www.ncbi.nlm.nih.gov/pubmed/32850399
http://dx.doi.org/10.3389/fonc.2020.01289

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7426525/
https://www.ncbi.nlm.nih.gov/pubmed/32850399
http://dx.doi.org/10.3389/fonc.2020.01289

Ejemplares similares